REFERENCES
- Wooten M R, Khangure M S, Murphy M J. Intracerebral hemorrhage and vasculitis related to ephedrine abuse. Ann Neurol 1983; 13: 337–340
- Loizou L A, Hamilton J G, Tsementzis S A. Intracranial hemorrhage in association with pseudoephedrine overdose. J Neurol Neurosurg Psychiatry 1982; 45: 471–475
- Glick R, Hoying J, Cerullo L, Perlman S. Phenylpropanolamine: An over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. Neurosurgery 1987; 20: 969–974
- Kase C S, Foster T E, Reed J E, Spatz E L, Girgis G N. Intracerebral hemorrhage and phenylpropanolamine use. Neurology 1987; 37: 399–404
- LeCoz P, Woimant F, Rougemont D, et al. Angiopathies cerebrales benigns et phenylpropanolamine. Rev Neurol 1988; 144: 295–300
- Leo P J, Hollander J E, Shih R D, Marcus S M. Phenylpropanolamine and associated myocardial injury. Ann Emerg Med 1996; 28: 359–362
- Rosenblum I, Wohl AStein A. Studies in cardiac necrosis: Production of cardiac lesions with sympathomimetic amines. Toxicol Appl Pharmacol 1965; 7: 1–8
- Chappel C J, Rong G. Balazst et al. Comparison of cardiotoxic actions of certain sympathomimetic anines. Can J Biochem Physiol 1959; 37: 35–42
- Szakacs J E, Cannon A. L-norepinephrine myocarditis. Am J Clin Pathol 1958; 30: 425–434
- Hyams J S, Leichtner A M, Breiner R G, et al. Pseudopheochromocytoma and cardiac arrest associated with phenylpropanolamine. JAMA 1985; 253: 1609–1610
- Pentel P R, Jentzen J, Sievert J. Myocardial necrosis due to intraperitoneal administration of phenylpropanolamine in rats. Fundam Appl Toxicol 1987; 9: 167–172
- Pentel P. Toxicity of over-the-counter stimulants. JAMA 1984; 252: 1898–1903
- Pentel P R, Mikell F L, Zavoral J H. Myocardial injury after phenylpropanolamine ingestion. Br Heart J 1982; 472: 51–54
- Wynne J, Braunwald E. The cardiomyopathies and myocarditis. In. Heart Disease: A Textbook of Cardiovascular Medicine, E. Braunwald. 5th ed, Philadelphia: WB Saunders. 1997; 1404–1463
- Personal Communication David Katzin, M.D., Ph.D.,Chairman of Medical Advisory Board. Herbalife. September, 11998
- To L B, Sangster J F, Rampling D, Cammens I. Ephedrine-induced cardiomyopathy. Med J Aust 1980; 2: 35–36